Literature DB >> 25601880

Ethical, legal and social implications of incorporating personalized medicine into healthcare.

Kyle B Brothers1, Mark A Rothstein2.   

Abstract

As research focused on personalized medicine has developed over the past decade, bioethics scholars have contemplated the ethical, legal and social implications of this type of research. In the next decade, there will be a need to broaden the focus of this work as personalized medicine moves into clinical settings. We consider two broad issues that will grow in importance and urgency. First, we analyze the consequences of the significant increase in health information that will be brought about by personalized medicine. Second, we raise concerns about the potential of personalized medicine to exacerbate existing disparities in healthcare.

Entities:  

Keywords:  ELSI issues; discrimination; ethical; health disparities; legal and social implication issues; personalized medicine; privacy

Year:  2015        PMID: 25601880      PMCID: PMC4296905          DOI: 10.2217/pme.14.65

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  38 in total

Review 1.  Socioeconomic disparities in health: pathways and policies.

Authors:  Nancy E Adler; Katherine Newman
Journal:  Health Aff (Millwood)       Date:  2002 Mar-Apr       Impact factor: 6.301

2.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

Review 3.  Genetic discrimination: international perspectives.

Authors:  M Otlowski; S Taylor; Y Bombard
Journal:  Annu Rev Genomics Hum Genet       Date:  2012-05-15       Impact factor: 8.929

4.  Pharmacogenetics and ethnically targeted therapies.

Authors:  Taslin Rahemtulla; Raj Bhopal
Journal:  BMJ       Date:  2005-05-07

5.  Merging and emerging cohorts: necessary but not sufficient.

Authors:  Francis S Collins; Teri A Manolio
Journal:  Nature       Date:  2007-01-18       Impact factor: 49.962

6.  Autonomy and paternalism in health policy: currents in contemporary bioethics.

Authors:  Mark A Rothstein
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

7.  Dreams and nightmares: practical and ethical issues for patients and physicians using personal health records.

Authors:  Matthew Wynia; Kyle Dunn
Journal:  J Law Med Ethics       Date:  2010       Impact factor: 1.718

Review 8.  Genome-wide association studies in diverse populations.

Authors:  Noah A Rosenberg; Lucy Huang; Ethan M Jewett; Zachary A Szpiech; Ivana Jankovic; Michael Boehnke
Journal:  Nat Rev Genet       Date:  2010-05       Impact factor: 53.242

9.  Personalized genomic medicine and the rhetoric of empowerment.

Authors:  Eric T Juengst; Michael A Flatt; Richard A Settersten
Journal:  Hastings Cent Rep       Date:  2012 Sep-Oct       Impact factor: 2.683

Review 10.  Predictive, personalized, preventive, participatory (P4) cancer medicine.

Authors:  Leroy Hood; Stephen H Friend
Journal:  Nat Rev Clin Oncol       Date:  2011-03       Impact factor: 66.675

View more
  15 in total

Review 1.  Importance of Genetic Studies of Cardiometabolic Disease in Diverse Populations.

Authors:  Lindsay Fernández-Rhodes; Kristin L Young; Adam G Lilly; Laura M Raffield; Heather M Highland; Genevieve L Wojcik; Cary Agler; Shelly-Ann M Love; Samson Okello; Lauren E Petty; Mariaelisa Graff; Jennifer E Below; Kimon Divaris; Kari E North
Journal:  Circ Res       Date:  2020-06-04       Impact factor: 17.367

2.  From "Personalized" to "Precision" Medicine: The Ethical and Social Implications of Rhetorical Reform in Genomic Medicine.

Authors:  Eric Juengst; Michelle L McGowan; Jennifer R Fishman; Richard A Settersten
Journal:  Hastings Cent Rep       Date:  2016-09       Impact factor: 2.683

Review 3.  Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma.

Authors:  Revati Sharma; George Kannourakis; Prashanth Prithviraj; Nuzhat Ahmed
Journal:  Front Med (Lausanne)       Date:  2022-06-14

4.  Clinician perspectives on communication and implementation challenges in precision oncology.

Authors:  Jada G Hamilton; Smita C Banerjee; Sigrid V Carlsson; Jacqueline Vera; Kathleen A Lynch; Lili Sar-Graycar; Chloé M Martin; Patricia A Parker; Jennifer L Hay
Journal:  Per Med       Date:  2021-10-22       Impact factor: 2.119

Review 5.  Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms.

Authors:  Jakub M Kwiecinski; Alexander R Horswill
Journal:  Curr Opin Microbiol       Date:  2020-03-12       Impact factor: 7.934

Review 6.  Challenges and opportunities for artificial intelligence in oncological imaging.

Authors:  H M C Cheung; D Rubin
Journal:  Clin Radiol       Date:  2021-04-24       Impact factor: 3.389

7.  Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?

Authors:  S J Bielinski; J L St Sauver; J E Olson; M L Wieland; C R Vitek; E J Bell; M E Mc Gree; D J Jacobson; J B McCormick; P Y Takahashi; J L Black; P J Caraballo; R R Sharp; T J Beebe; R M Weinshilboum; L Wang; V L Roger
Journal:  Pharmacogenomics J       Date:  2016-10-25       Impact factor: 3.550

8.  Tensions in ethics and policy created by National Precision Medicine Programs.

Authors:  Jusaku Minari; Kyle B Brothers; Michael Morrison
Journal:  Hum Genomics       Date:  2018-04-17       Impact factor: 4.639

9.  Perceptions of students in health and molecular life sciences regarding pharmacogenomics and personalized medicine.

Authors:  Lejla Mahmutovic; Betul Akcesme; Camil Durakovic; Faruk Berat Akcesme; Aida Maric; Muhamed Adilovic; Nour Hamad; Matthias Wjst; Oliver Feeney; Sabina Semiz
Journal:  Hum Genomics       Date:  2018-11-14       Impact factor: 4.639

10.  Intellectual Structure and Evolutionary Trends of Precision Medicine Research: Coword Analysis.

Authors:  Xiaoguang Lyu; Jiming Hu; Weiguo Dong; Xin Xu
Journal:  JMIR Med Inform       Date:  2020-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.